spacer
spacer

PDBsum entry 2fue

Go to PDB code: 
protein ligands metals links
Isomerase PDB id
2fue

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
246 a.a. *
Ligands
M1P
Metals
_MG ×2
Waters ×238
* Residue conservation analysis
PDB id:
2fue
Name: Isomerase
Title: Human alpha-phosphomannomutase 1 with d-mannose 1-phosphate and mg2+ cofactor bound
Structure: Phosphomannomutase 1. Chain: a. Synonym: pmm 1, pmmh-22. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Dimer (from PDB file)
Resolution:
1.75Å     R-factor:   0.204     R-free:   0.240
Authors: N.R.Silvaggi,C.Zhang,Z.Lu,D.Dunaway-Mariano,K.N.Allen
Key ref:
N.R.Silvaggi et al. (2006). The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a. J Biol Chem, 281, 14918-14926. PubMed id: 16540464 DOI: 10.1074/jbc.M601505200
Date:
26-Jan-06     Release date:   21-Mar-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q92871  (PMM1_HUMAN) -  Phosphomannomutase 1 from Homo sapiens
Seq:
Struc:
262 a.a.
246 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.5.4.2.8  - phosphomannomutase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
GDP-L-Fucose and GDP-mannose Biosynthesis
      Reaction: alpha-D-mannose 1-phosphate = D-mannose 6-phosphate
alpha-D-mannose 1-phosphate
Bound ligand (Het Group name = M1P)
corresponds exactly
= D-mannose 6-phosphate
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1074/jbc.M601505200 J Biol Chem 281:14918-14926 (2006)
PubMed id: 16540464  
 
 
The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a.
N.R.Silvaggi, C.Zhang, Z.Lu, J.Dai, D.Dunaway-Mariano, K.N.Allen.
 
  ABSTRACT  
 
Congenital disorder of glycosylation type 1a (CDG-1a) is a congenital disease characterized by severe defects in nervous system development. It is caused by mutations in alpha-phosphomannomutase (of which there are two isozymes, alpha-PMM1 and alpha-PPM2). Here we report the x-ray crystal structures of human alpha-PMM1 in the open conformation, with and without the bound substrate, alpha-D-mannose 1-phosphate. Alpha-PMM1, like most haloalkanoic acid dehalogenase superfamily (HADSF) members, consists of two domains, the cap and core, which open to bind substrate and then close to provide a solvent-exclusive environment for catalysis. The substrate phosphate group is observed at a positively charged site of the cap domain, rather than at the core domain phosphoryl-transfer site defined by the Asp(19) nucleophile and Mg(2+) cofactor. This suggests that substrate binds first to the cap and then is swept into the active site upon cap closure. The orientation of the acid/base residue Asp(21) suggests that alpha-phosphomannomutase (alpha-PMM) uses a different method of protecting the aspartylphosphate from hydrolysis than the HADSF member beta-phosphoglucomutase. It is hypothesized that the electrostatic repulsion of positive charges at the interface of the cap and core domains stabilizes alpha-PMM1 in the open conformation and that the negatively charged substrate binds to the cap, thereby facilitating its closure over the core domain. The two isozymes, alpha-PMM1 and alpha-PMM2, are shown to have a conserved active-site structure and to display similar kinetic properties. Analysis of the known mutation sites in the context of the structures reveals the genotype-phenotype relationship underlying CDG-1a.
 
  Selected figure(s)  
 
Figure 1.
FIGURE 1. Scheme for the reaction catalyzed by human -phosphomannomutase. The C-1 and C-6 positions on the hexose ring are labeled in the first step.
Figure 2.
FIGURE 2. A, structure of human -phosphomannomutase complexed with -D-mannose 1-phosphate. The cap domain is magenta and the core domain cyan. Man-1-P is shown as ball-and-stick (orange) and the two Mg^2+ ions as metallic spheres. The image was rendered using MOL-SCRIPT (38) and POVRAY. B, schematic representation of the arrangement of secondary structure elements in -PMM1 core (cyan) and cap (magenta).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2006, 281, 14918-14926) copyright 2006.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20512605 H.Y.Chu, Q.C.Zheng, X.Li, Y.S.Zhao, J.L.Zhang, and H.X.Zhang (2011).
DFT investigation on the reaction mechanism catalyzed by α-phosphomannomutase1 in protonated/deprotonated states.
  J Mol Model, 17, 577-585.  
20920368 C.Yu, Y.Li, B.Li, X.Liu, L.Hao, J.Chen, W.Qian, S.Li, G.Wang, S.Bai, H.Ye, H.Qin, Q.Shen, L.Chen, A.Zhang, and D.Wang (2010).
Molecular analysis of phosphomannomutase (PMM) genes reveals a unique PMM duplication event in diverse Triticeae species and the main PMM isozymes in bread wheat tissues.
  BMC Plant Biol, 10, 214.  
20661555 R.Quental, A.Moleirinho, L.Azevedo, and A.Amorim (2010).
Evolutionary history and functional diversification of phosphomannomutase genes.
  J Mol Evol, 71, 119-127.  
19289054 A.Suenaga, M.Hatakeyama, A.B.Kiyatkin, R.Radhakrishnan, M.Taiji, and B.N.Kholodenko (2009).
Molecular dynamics simulations reveal that Tyr-317 phosphorylation reduces Shc binding affinity for phosphotyrosyl residues of epidermal growth factor receptor.
  Biophys J, 96, 2278-2288.  
19339218 H.H.Freeze (2009).
Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients.
  Biochim Biophys Acta, 1792, 835-840.  
19154134 J.Dai, L.Finci, C.Zhang, S.Lahiri, G.Zhang, E.Peisach, K.N.Allen, and D.Dunaway-Mariano (2009).
Analysis of the structural determinants underlying discrimination between substrate and solvent in beta-phosphoglucomutase catalysis.
  Biochemistry, 48, 1984-1995.
PDB code: 3fm9
19862844 M.A.Haeuptle, and T.Hennet (2009).
Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.
  Hum Mutat, 30, 1628-1641.  
18927083 M.Veiga-da-Cunha, W.Vleugels, P.Maliekal, G.Matthijs, and E.Van Schaftingen (2008).
Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase.
  J Biol Chem, 283, 33988-33993.  
17166182 D.Quelhas, R.Quental, L.Vilarinho, A.Amorim, and L.Azevedo (2007).
Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
  Ann Hum Genet, 71, 348-353.  
17786587 G.N.Phillips, B.G.Fox, J.L.Markley, B.F.Volkman, E.Bae, E.Bitto, C.A.Bingman, R.O.Frederick, J.G.McCoy, B.L.Lytle, B.S.Pierce, J.Song, and S.N.Twigger (2007).
Structures of proteins of biomedical interest from the Center for Eukaryotic Structural Genomics.
  J Struct Funct Genomics, 8, 73-84.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer